Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 2, 2023.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
In recognition of World MS Day, Meghan Beier, PhD, MA, a health and rehabilitation psychologist at the Rowan Center for Behavioral Medicine, discussed the effects of multiple sclerosis (MS) on cognitive function.
In episode 12 of this Peer Exchange series on "The Shifting Treatment Landscape of RRMS", experts in neurology provide insight on challenges that arise with the use of generic DMTs in RRMS treatment, such as cost to the patient.
In the latest edition of our in-depth Q&A series, Cornelia Drees, MD, senior associate consultant, Department of Neurology, Mayo Clinic, discussed the potential of microburst vagus nerve stimulation as a more targeted treatment for drug-resistant epilepsy.
Andrew Solomon, MD, associate professor of neurological sciences and Chief of the Multiple Sclerosis Division at the University of Vermont in Burlington, discussed inherent biases affecting MS diagnosis and how advances in imaging may help curb diagnostic errors.
The professor of molecular neuroscience at the Edmond and Lily Safra Center for Brain Sciences discussed the premise behind a study of RNA-sequencing data to better understand the reasons why females suffer accelerated dementia. [WATCH TIME: 9 minutes]